CN110623992B - Preparation and application of folium artemisiae argyi carbon quantum dots (nanoparticles/nanoparticles) - Google Patents

Preparation and application of folium artemisiae argyi carbon quantum dots (nanoparticles/nanoparticles) Download PDF

Info

Publication number
CN110623992B
CN110623992B CN201810658499.3A CN201810658499A CN110623992B CN 110623992 B CN110623992 B CN 110623992B CN 201810658499 A CN201810658499 A CN 201810658499A CN 110623992 B CN110623992 B CN 110623992B
Authority
CN
China
Prior art keywords
folium artemisiae
artemisiae argyi
quantum dots
charcoal
carbon quantum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201810658499.3A
Other languages
Chinese (zh)
Other versions
CN110623992A (en
Inventor
屈会化
赵琰
王庆国
孔慧
朱雅凡
张越
成金俊
鲁放
孙紫薇
张美龄
闫昕
曹鹏
宋兴兴
罗娟
熊威
王苏娜
王晓克
侯婷婷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing University of Chinese Medicine
Original Assignee
Beijing University of Chinese Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing University of Chinese Medicine filed Critical Beijing University of Chinese Medicine
Priority to CN201810658499.3A priority Critical patent/CN110623992B/en
Publication of CN110623992A publication Critical patent/CN110623992A/en
Application granted granted Critical
Publication of CN110623992B publication Critical patent/CN110623992B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/44Elemental carbon, e.g. charcoal, carbon black
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/282Artemisia, e.g. wormwood or sagebrush
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y20/00Nanooptics, e.g. quantum optics or photonic crystals
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00Nanotechnology for materials or surface science, e.g. nanocomposites
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y40/00Manufacture or treatment of nanostructures
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/08Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
    • C09K11/65Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing carbon

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nanotechnology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Optics & Photonics (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Mycology (AREA)
  • Manufacturing & Machinery (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Obesity (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)

Abstract

The invention relates to a method for extracting, separating and purifying quantum dots (nano particles/nano particles) from folium artemisiae argyi charcoal, which comprises the following steps: the folium artemisiae argyi charcoal is extracted or extracted by a solvent, and dialyzed by a dialysis bag with the molecular weight of more than 1000Da or ultrafiltered to obtain folium artemisiae argyi charcoal quantum dots, wherein the quantum dots are blue fluorescence under an ultraviolet lamp of 365nm, have the particle size of less than 100nm measured by a transmission electron microscope and mainly comprise C, H, O, N and other elements; the invention also relates to the application of the quantum dot in the field of medicine, which is used for resisting inflammation, improving the tolerance degree of the body to cold and the like after administration by injection, oral administration or external application and the like.

Description

Preparation and application of folium artemisiae argyi carbon quantum dots (nanoparticles/nanoparticles)
Technical Field
The invention belongs to the technical field of medicines, and particularly relates to preparation of folium artemisiae argyi carbon quantum dots and application of the folium artemisiae argyi carbon quantum dots in the field of medicines.
Background
Since ancient times, methods of treating diseases with charcoal are widely described in medical books of the past dynasties. The pharmacopoeia of the people's republic of China records that it has the functions of warming meridians, stopping bleeding, dispelling cold and relieving pain. The preparation method of the folium artemisiae argyi charcoal mainly comprises the following four methods:
1. direct firing method: cleaning folium Artemisiae Argyi, drying, burning on alcohol burner until dense smoke is formed, burning completely to form cellular loose carbon block, and filtering with Gong or gauze.
2. Pan-frying: cleaning folium Artemisiae Argyi, air drying, parching with slow fire for half an hour until concentrated into mass and dense smoke becomes gradually light into charcoal.
3. A closed-burning method: and (4) collecting folium artemisiae argyi, rinsing with clear water and drying. A small pot or a pot with holes is covered on the pot or the porcelain container. Sealing the joint of the two pots with mud, pressing a weight on the pot, and calcining with slow and strong fire. Generally, the rice or white paper covered on the pot is burnt to be yellow.
4. Baking: placing the folium artemisiae argyi in a drying oven at 275-280 ℃, drying until the thermometer smokes and takes out the folium artemisiae argyi when the folium artemisiae argyi has slight fishy smell.
The folium artemisiae argyi charcoal mainly comprises inorganic elements such as carbon, nitrogen and calcium.
Disclosure of Invention
The quantum dots (nano particles/nano particles) are extracted and separated from the folium artemisiae argyi carbon for the first time, and the folium artemisiae argyi carbon quantum dots are found to have strong biological effects of improving the tolerance degree of animals to cold, resisting inflammation and the like for the first time. The technical scheme is as follows: the invention provides a method for extracting and separating carbon quantum dots from folium artemisiae argyi carbon. The invention also provides the biological activity of the folium artemisiae argyi carbon quantum dots and the application of the folium artemisiae argyi carbon quantum dots in the field of medicines.
The preparation method specifically comprises the following steps: baking to prepare folium Artemisiae Argyi charcoal, extracting quantum dots from folium Artemisiae Argyi charcoal with solvent, and further separating and purifying by dialysis, ultrafiltration, chromatography, etc. to obtain high purity carbon quantum dots.
Drawings
FIG. 1 is a high performance liquid chromatogram of folium Artemisiae Argyi FIG. 1(a) and folium Artemisiae Argyi carbon quantum dot diagram 1(b)
FIG. 2 shows a morphology chart of folium Artemisiae Argyi carbon quantum dot under a transmission electron microscope 2(a), a high resolution transmission electron microscope 2(b), an X-ray diffraction chart 2(c), an ultraviolet spectrum chart 2(d), a fluorescence spectrum chart 2(e), and an infrared spectrum chart 2(f)
FIG. 3 shows the X-ray photoelectron spectrum 3(a), the carbon spectrum 3(b), the oxygen spectrum 3(c), and the nitrogen spectrum 3(d) of the quantum dot of folium Artemisiae Argyi carbon
FIG. 4 shows the effect of different doses of folium Artemisiae Argyi charcoal quantum dots on the concentration of interleukin 1-beta in mouse serum 4(a), the effect on the concentration of tumor necrosis factor in mouse serum 4(b), and the anti-mouse-freezing effect 4 (c).
FIG. 5 is a photograph and a slice of folium artemisiae argyi carbon quantum dots with different dosages for preventing and treating frostbite of mouse ear margins
Detailed Description
Example 1: preparation of folium artemisiae argyi carbon quantum dots
Weighing clean folium Artemisiae Argyi, placing in a crucible, covering, placing in a muffle furnace, heating to 285 deg.C, maintaining constant temperature for 1h, naturally cooling to room temperature, opening the muffle furnace, and taking out to obtain folium Artemisiae Argyi charcoal.
Extracting folium Artemisiae Argyi charcoal with pure water for 3 times, mixing the water solutions, concentrating, and dialyzing with 1KD dialysis bag, wherein the part in the dialysis bag is high-purity folium Artemisiae Argyi charcoal carbon quantum dot solution.
Example 2: preparation of folium artemisiae argyi carbon quantum dots
Weighing clean folium Artemisiae Argyi, placing in a crucible, covering, placing in a muffle furnace, heating to 350 deg.C, maintaining constant temperature for 1h, naturally cooling to room temperature, opening the muffle furnace, and taking out to obtain folium Artemisiae Argyi charcoal.
Extracting folium Artemisiae Argyi charcoal with pure water for 3 times, mixing the water solutions, concentrating, and ultrafiltering with 10KD ultrafilter tube to obtain high purity folium Artemisiae Argyi charcoal carbon quantum dot solution.
Example 3 folium Artemisiae Argyi carbon quantum dots improve the tolerance of the body to cold
Anti-freezing experiment of mice:
1. the night before the experiment was fasted for 12 hours and fed normally. On the day of the experiment, the mice are weighed and divided into physiological saline groups; a group of positive drugs; a high dose group; a medium dose group; low dose group.
2. The labeled mice are separately packaged for later use. The drugs were administered two hours prior to the experiment, respectively, to allow for adequate absorption of the drug. After the holding power of each mouse is measured, the mouse is placed in ice water with the temperature of 0 ℃, is fished out after swimming for 5 minutes, and the holding power is measured again in time, and the relative change value of the holding power is calculated, so that the reaction stiffness degree is obtained.
3. The results are shown in fig. 4, and the three doses, high, medium and low, all have significant anti-freeze effects compared to the normal group (blank group shows that there is still a certain relative change in the mouse's grip without ice-water bath.
The anti-freezing effect of the mouse is as follows:
1. the night before the experiment was fasted for 12 hours and fed normally. The mice were weighed and labeled the day of the experiment.
2. Two hours before the experiment, the mice are subjected to modeling for one week in the ice-water bath method, the mice are killed 12 hours after the last modeling, the serum of the mice is taken to measure inflammatory factors, and the frozen ear margins of the mice are taken to be subjected to HE staining and slicing.
3. The results are shown in fig. 4 and fig. 5, and the high, medium and low doses all have anti-freezing effect compared with the normal group, so that the injury of cold stimulation to mouse tissues can be effectively reduced, and the level of inflammatory factors can be reduced.

Claims (2)

1. The application of the folium artemisiae argyi carbon quantum dots in preparing the medicine for treating frostbite comprises the following steps: placing folium Artemisiae Argyi in a crucible, covering, placing in a muffle furnace, heating to 285 deg.C or 350 deg.C, maintaining constant temperature for 1 hr, naturally cooling to room temperature, and taking out to obtain folium Artemisiae Argyi charcoal; extracting folium Artemisiae Argyi charcoal with pure water, dialyzing with dialysis bag with molecular weight of 1-10 KDa, collecting the fraction retained in the dialysis bag, or ultrafiltering with ultrafiltration tube of 10KD, and collecting the filtrate fraction to obtain folium Artemisiae Argyi charcoal quantum dot; the characteristics of the obtained carbon quantum dots: blue fluorescence under an ultraviolet lamp of 365nm, the particle size measured by a transmission electron microscope is 1-20nm, and the elements of the quantum dots mainly comprise C, O and N elements.
2. The use of claim 1, in the form of injection, oral liquid, hard capsule, soft capsule, tablet, suppository, watered pill, honeyed pill, concentrated pill, paste, powder, emulsion, paste, or liniment.
CN201810658499.3A 2018-06-22 2018-06-22 Preparation and application of folium artemisiae argyi carbon quantum dots (nanoparticles/nanoparticles) Active CN110623992B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810658499.3A CN110623992B (en) 2018-06-22 2018-06-22 Preparation and application of folium artemisiae argyi carbon quantum dots (nanoparticles/nanoparticles)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810658499.3A CN110623992B (en) 2018-06-22 2018-06-22 Preparation and application of folium artemisiae argyi carbon quantum dots (nanoparticles/nanoparticles)

Publications (2)

Publication Number Publication Date
CN110623992A CN110623992A (en) 2019-12-31
CN110623992B true CN110623992B (en) 2022-03-18

Family

ID=68967108

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810658499.3A Active CN110623992B (en) 2018-06-22 2018-06-22 Preparation and application of folium artemisiae argyi carbon quantum dots (nanoparticles/nanoparticles)

Country Status (1)

Country Link
CN (1) CN110623992B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110623996A (en) * 2018-06-22 2019-12-31 北京中医药大学 Preparation and application of schizonepeta spike carbon quantum dots (nanoparticles/nanoparticles)
CN111248190B (en) * 2020-03-19 2021-04-27 中国科学院化学研究所 Application of carbon dots as antifreeze material
CN111840100A (en) * 2020-08-06 2020-10-30 郑州大学 Antibacterial washing and protecting liquid based on antibacterial carbon nanodots, and preparation method and application thereof
CN114569648A (en) * 2020-12-01 2022-06-03 北京中医药大学 Preparation and application of carbon nano particles of sophora flavescens

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Novel carbon dots derived from Schizonepetae Herba Carbonisata and investigation of their haemostatic efficacy;Meiling Zhang et al;《Artificial Cells,Nanomedicine, and Biotechnology》;20170919;第46卷(第8期);第1562-1571页,尤其是第1563页右栏第2-3段,第1565页左栏最后一段,第1565页右栏,第1566页左栏第1段 *

Also Published As

Publication number Publication date
CN110623992A (en) 2019-12-31

Similar Documents

Publication Publication Date Title
CN110623992B (en) Preparation and application of folium artemisiae argyi carbon quantum dots (nanoparticles/nanoparticles)
CN117959374A (en) Preparation method and application of medicinal and edible traditional Chinese medicine health care moxibustion fumigating and drinking composition
CN103142987B (en) Medicament for treating mumps
CN109331043A (en) A kind of pharmaceutical composition and preparation method thereof for treating ulcer malignant boil furuncle
CN104304629A (en) Traditional Chinese medicine fragrant chewing gum
CN110623990B (en) Preparation and application of Cirsium setosum carbon quantum dots (nanoparticles/nanoparticles)
CN105381069A (en) Traditional Chinese medicine oral liquid for treating hypertension
CN106924371A (en) A kind of lepidium seed date is tonified the kidney to improve inspiration and controls asthma oral liquid
CN104706998A (en) Traditional Chinese medicine spray for treating allergic rhinitis in clinical care and preparation method thereof
WO2007059649A1 (en) Chinese pharmaceutical compositions for treating upper respiratory tract infection and processes for preparation thereof
CN104473268A (en) Honeysuckle-containing beverage and preparation method thereof
CN117462620B (en) Traditional Chinese medicine formula for treating lung cancer and preparation method and application thereof
CN107648494A (en) One kind treats gingivitis and canker sore Chinese medical collutory and preparation method thereof
CN116173170B (en) A pharmaceutical composition for treating respiratory diseases, and its preparation method
CN106266504A (en) A kind of Chinese medicine of nourishing the lung to arrest cough
CN106266737A (en) Congenital whole body hirsutism and treatment Chinese medicine thereof
CN106215022A (en) A kind of containing Herba Androsaces Umbellatae (Herba Androsaces Coccineae) sore-throat relieving Chinese medicine and preparation method
WO2006029550A1 (en) Hemostatic mistura of ipomoea balatas leaves, methods of preparation and use thereof
CN107661374A (en) A kind of special efficacy cold drug and preparation method thereof
CN104510784A (en) Insomnia treatment traditional Chinese medicine composition
CN105030936A (en) Chinese medicine for treating keratoconjunctivitis
CN105168821A (en) Cough-relieving traditional Chinese medicine composition and preparation method thereof
CN1245204C (en) Medicine for curing acute pharyngitis and its preparing method
CN104906379A (en) Traditional Chinese medicine ointment for treating bullous impetigo and preparation method of ointment
CN105169123B (en) A kind of traditional Chinese medicine powder and preparation method thereof for treating children's extreme noxious heat varicella

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant